Market Overview:
The global biopreservation market size reached US$ 6.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 13.5 Billion by 2028, exhibiting a growth rate (CAGR) of 11.7% during 2023-2028.
Biopreservation refers to the use of natural or controlled antibacterial products to preserve and bank various biospecimens, such as cells, plasma, saliva, tissues, and organs, outside of its native environment. The equipment comprises freezers, refrigerators, and liquid nitrogen banks that ensures the purity and stability of the biological materials, thereby extending its shelf life. Biopreservation exhibits non-toxic, non-immunogenic, broad bactericidal activity, and thermo-resistance properties due to which, it is being widely adopted in healthcare facilities for various clinical applications, such as storing clinical trial materials, genomics research, organ transplantation, cell-based study, and personalized medicine. Apart from this, it is also employed in the food sector to extend the shelf life of the end-product as it exploits the antimicrobial activities of pathogens on food items.
Biopreservation Market Trends:
The biopreservation market is majorly being driven by the growing use of biospecimens in medical research for developing novel therapies and drugs. In line with this, the rising instances of various chronic diseases, such as cancer and diabetes, degenerative conditions, and neurological disorders, are further facilitating the demand for regenerative medicine, wherein the cellular components of biopreservation are used to restore the normal functioning of damaged tissues. The increasing prevalence of biobanking is also acting as another major growth-inducing factor. Additionally, increasing healthcare expenditure, particularly in emerging economies, along with rapid advancements in biopreservation methods and equipment are further catalyzing the market growth. Moreover, governments of various nations are implementing favorable policies and continuously investing in the research and development (R&D) activities to support stem cell therapies and enhance bio-banking and preservation standards. This, in turn, is creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global biopreservation market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on product type and application.
Breakup by Product Type:
- Biopreservation Equipment
- Biopreservation Media
Breakup by Application:
- Therapeutic Applications
- Biobank Applications
- Drug Discovery Applications
Breakup by Region:
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Competitive Landscape:
Some of the major players in the market are BioLife Solutions, Inc., Thermo Fisher Scientific Inc., VWR International, LLC, Panasonic Corporation and BioCision LLC.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2022 |
Historical Period |
2017-2022 |
Forecast Period |
2023-2028 |
Units |
US$ Billion |
Segment Coverage |
Product Type, Application, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Companies Covered |
BioLife Solutions, Inc., Thermo Fisher Scientific Inc., VWR International, LLC, Panasonic Corporation and BioCision LLC |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |